XVARY Composite Score
52
/ 100
Below Average
Combines growth, value, risk, and momentum factors into a single institutional-grade score.
Start here if you're new
What it is
Sensient makes colors, flavors, and fragrances for packaged food, drinks, and cosmetics.
How it gets paid
Last year Sensient Tech made $1.6B in revenue. Flavors & Extracts was the main engine at $0.8B, or 49% of sales.
Why it's growing
Revenue grew 3.5% last year. However, the color group segment was a meaningful contributor of growth in the third quarter, led by a 10% sales gain and significant operating income.
What just happened
Sensient missed by 24.1% last quarter, which is a bad look for a stock at 28.4x profit.
At a Glance
B++ balance sheet — above average — nothing keeping you up at night
70/100 earnings predictability — reasonably predictable
28.4x trailing p/e — priced about right
1.8% dividend yield — cash in your pocket every quarter
10.5% return on capital — nothing to write home about
XVARY composite: 52/100 — below average
What They Do
Sensient makes colors, flavors, and fragrances for packaged food, drinks, and cosmetics.
You do not swap a color supplier because your cereal looks a shade off. Sensient runs 75 locations in 35 countries, and 42% of sales come from outside North America. That mix makes leaving painful for your customers and sticky for you.
How They Make Money
$1.6B
annual revenue · their business grew +3.5% last year
Flavors & Extracts
$0.8B
+3.5%
Color
$0.6B
+10.0%
Asia Pacific
$0.2B
+3.5%
The Products That Matter
Specialty ingredient formulation
Flavors, fragrances & colors
$1.6B revenue
it's the entire $1.6B business, and the color group alone posted 10% sales growth in the quarter. that tells you where the momentum is.
core
Natural colors expansion
Natural colors
10% segment growth
management is pushing this category ahead of end-2027 regulatory deadlines, and the company says cost actions can save $8M–$10M annually while the mix shifts.
growth pocket
Portfolio optimization
Synthetic color consolidation
$8M–$10M savings
since late 2023, Sensient has been consolidating underperforming synthetic color capacity. on a $1.6B base, that will not change the story alone, but it can support margins while demand stays modest.
margin lever
Key Numbers
$1.6B
annual revenue
You are buying a $1.6B ingredients business, not a tiny niche lab. That size helps it stay relevant with big food and beauty buyers.
28.4x
trailing p/e
You pay 28.4 times trailing profit. That is a rich price for a business with 3.5% projected sales growth.
18.5%
operating margin
For every $100 of sales, $18.50 stays after operating costs. That cushion helps when customers push back on price.
10.5%
return on capital
Each $100 invested in the business earns $10.50 in operating profit. That is solid, but it is not cheap capital sloshing around.
Financial Health
B++
Strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 80 / 100
- long-term debt $711M (15% of capital)
- net profit margin 11.1% — keeps 11 cents of every dollar in revenue
- return on equity 14% — $0.14 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total Return vs. Market
You invested $10000 in SXT 3 years ago → it's now worth $13760.
The index would have given you $13920.
source: institutional data · total return
What Just Happened
missed estimates
Sensient missed by 24.1% last quarter, which is a bad look for a stock at 28.4x profit.
Consensus had $0.79 in EPS and $0.60 came out. Management also pointed to $8M to $10M in annual cost savings, which is what companies say when growth is doing less heavy lifting.
$1.6B
revenue
$0.60
eps
18.5%
operating margin
miss size
The 24.1% miss matters because premium-priced stocks get punished when earnings wobble.
-
Operating momentum likely continued through for sensient technologies in the final stanza of 2025.since late 2023, the company successfully implemented a portfolio optimization plan, which included consolidating underperforming synthetic color production facilities.
-
Management outlined annual cost savings between $8 million and $10 million last year.this has allowed the company to focus on accelerating the adoption of natural colors, particularly ahead of regulatory deadlines by year-end 2027. meanwhile, revenue growth has been modest with tariff headwinds and challenges in the north american and european food and beverage market, hurting volumes (namely in asia pacific).
-
However, the color group segment was a meaningful contributor of growth in the third quarter, led by a 10% sales gain and significant operating income growth.
-
This was driven by strength in the food and pharmaceutical colors arm.for the full year, profits likely advanced at a double-digit clip, outpacing revenue growth in the low-single-digit range. bottom-line improvement reflected productivity initiatives and a favorable mix as natural color ingredients gain traction.
-
We have raised our 2026 shareearnings call by $0.50, to $4.00.operational adjustments and the continued focus on higher-margin natural ingredients should support bottom-line growth. we think the company will continue to benefit from regulatory-driven industry shifts toward clean-label and plantbased products.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.
Weekly updates
Earnings alerts
Plain English
No spam
What Could Go Wrong
The top risk is the natural-colors transition arriving before customer volumes do.
Med
Natural-colors transition execution
Sensient is positioning for higher demand in natural colors ahead of end-2027 regulatory deadlines. that is the growth story. if customers move slower than expected, the stock is left with a premium multiple and only modest base-business growth.
10% color-group growth is strong. it needs to stay strong enough to matter inside a $1.6B company.
Med
Volume softness in food and beverage
management already called out pressure in north american and european food and beverage markets, with weaker volumes in asia pacific too. on a business that grew 3.5% last year, you do not have a huge cushion for more softness.
a 10.2% net margin business can absorb some demand wobble. it cannot absorb endless wobble while keeping a 28.4x multiple.
Med
Tariff and input-cost pressure
tariff pressure is already in management commentary. For a global ingredient supplier, cost inflation and compliance costs squeeze the spread between what goes in and what comes out.
the recent 8.3% quarterly margin shows there is profit cushion, but not a luxurious one.
Med
Multiple compression without bad operations
the stock trades at $95 while the 3–5 year target midpoint sits at $87. sometimes the risk is not that the business breaks. it's that the stock already assumes the good part.
even if operations stay decent, you can get a flat stock while earnings do the catching up.
At $95.25, SXT sits about 9% above the $87 midpoint target while the business is growing 3.5% and earning a 10.2% net margin. That is a workable setup for a good company, not a forgiving setup for a miss.
Source: institutional data · regulatory filings · risk analysis
Pay Attention To
Trend
Color growth versus company growth
the color group grew 10% in the quarter while the full company grew 3.5% last year. that gap is the whole story.
Metric
Margin hold above the recent 8.3%
if quarterly margin keeps improving from 8.3%, the EPS story stays intact. if it fades, the valuation gets harder to defend.
Calendar
End-2027 regulatory deadlines
management is leaning into natural colors ahead of those deadlines. you want adoption to show up before the deadline, not after it.
Risk
Price versus the $87 midpoint
the stock is already above the midpoint target. that leaves less room for weak volumes, tariff pressure, or a softer mix shift.
Analyst Rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts think the next stretch could be choppy even if the business itself stays stable.
risk profile
average
stability score 3 — this is neither a bunker stock nor a rollercoaster.
chart momentum
top 20%
technical score 2 — the chart looks better than the fundamental ranking, which is another way of saying sentiment has outrun the business a bit.
earnings predictability
70 / 100
predictable enough for a specialty-ingredients name, but not so steady that you should ignore quarterly execution.
Source: institutional data
Institutional Activity
institutions have been net buying for 2 consecutive quarters — 156 buyers vs. 142 sellers in 3q2025. total institutional holdings: 41.7M shares. net buying for 2 quarters.
Source: institutional data
Price Targets
3-5 year target range
$57
$117
$95
Current price
$87
Target midpoint · 9% from current · 3-5yr high: $117
Want the deeper analysis?
The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
See plans from $5/moThe Deep Dive